4//SEC Filing
Link David Charles 4
Accession 0000950170-24-084296
CIK 0001833214other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:30 PM ET
Size
7.8 KB
Accession
0000950170-24-084296
Insider Transaction Report
Form 4
Link David Charles
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-15+20,000→ 20,000 totalExercise: $2.90Exp: 2034-07-15→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2024-07-15+9,305→ 9,305 totalExercise: $2.90Exp: 2034-07-15→ Common Stock (9,305 underlying)
Footnotes (3)
- [F1]Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer (the "Board"). Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026.
- [F2]Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option vest in three equal annual installments on July 15, 2025, 2026, and 2027.
- [F3]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001889464
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:30 PM ET
- Size
- 7.8 KB